{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:15:31Z","timestamp":1791098131641,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM128621"],"award-info":[{"award-number":["R35 GM128621"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1 TR001428"],"award-info":[{"award-number":["TL1 TR001428"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1 TR001428"],"award-info":[{"award-number":["TL1 TR001428"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR00142"],"award-info":[{"award-number":["UL1 TR00142"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR00142"],"award-info":[{"award-number":["UL1 TR00142"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Mycoplasmas primarily cause respiratory or urogenital tract infections impacting avian, bovine, canine, caprine, murine, and reptilian hosts. In animal husbandry, mycoplasmas cause reduced feed-conversion, decreased egg production, arthritis, hypogalactia or agalactia, increased condemnations, culling, and mortality in some cases. Antibiotics reduce transmission and mitigate clinical signs; however, concerning levels of antibiotic resistance in<jats:italic>Mycoplasma gallisepticum<\/jats:italic>and<jats:italic>M. capricolum<\/jats:italic>isolates exist. To address these issues, we evaluated the minimum inhibitory concentrations (MICs) of halogenated phenazine and quinoline compounds, an<jats:italic>N-<\/jats:italic>arylated NH125 analogue, and triclosan against six representative veterinary mycoplasmas via microbroth or agar dilution methods. Thereafter, we evaluated the minimum bactericidal concentration (MBC) of efficacious drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified several compounds with MICs \u226425\u2009\u03bcM against<jats:italic>M. pulmonis<\/jats:italic>(<jats:italic>n<\/jats:italic>\u2009=\u20095),<jats:italic>M. capricolum<\/jats:italic>(<jats:italic>n<\/jats:italic>\u2009=\u20094),<jats:italic>M. gallisepticum<\/jats:italic>(<jats:italic>n<\/jats:italic>\u2009=\u20093),<jats:italic>M. alligatoris<\/jats:italic>(n\u2009=\u20093),<jats:italic>M. agassizii<\/jats:italic>(<jats:italic>n<\/jats:italic>\u2009=\u20092), and<jats:italic>M. canis<\/jats:italic>(<jats:italic>n<\/jats:italic>\u2009=\u20091). An<jats:italic>N-<\/jats:italic>arylated NH125 analogue, compound 21, served as the most efficacious, having a MIC \u226425\u2009\u03bcM against all mycoplasmas tested, followed by two quinolines, nitroxoline (compound 12) and compound 20, which were effective against four and three mycoplasma type strains, respectively. Nitroxoline exhibited bactericidal activity among all susceptible mycoplasmas, and compound 21 exhibited bactericidal activity when the MBC was able to be determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These findings highlight a number of promising agents from novel drug classes with potential applications to treat veterinary mycoplasma infections and present the opportunity to evaluate preliminary pharmacokinetic indices using<jats:italic>M. pulmonis<\/jats:italic>in rodents as an animal model of human infection.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-020-02324-4","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T17:03:28Z","timestamp":1586192608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy data of halogenated phenazine and quinoline agents and an NH125 analogue to veterinary mycoplasmas"],"prefix":"10.1186","volume":"16","author":[{"given":"Marissa A.","family":"Valentine-King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret O.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Robert W.","family":"Huigens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary B.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"key":"2324_CR1","first-page":"807","volume-title":"Diseases of poultry","author":"DH Ley","year":"2008","unstructured":"Ley DH. Mycoplasma gallisepticum infection. In: Saif YM, editor. Diseases of poultry. Ames, Iowa: Blackwell Publishing; 2008. p. 807\u201334."},{"issue":"1","key":"2324_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tvjl.2013.04.015","volume":"198","author":"A G\u00f3mez-Mart\u00edn","year":"2013","unstructured":"G\u00f3mez-Mart\u00edn A, Amores J, Paterna A, De la Fe C. Contagious agalactia due to Mycoplasma spp. in small dairy ruminants: epidemiology and prospects for diagnosis and control. Vet J. 2013;198(1):48\u201356.","journal-title":"Vet J"},{"issue":"2","key":"2324_CR3","first-page":"537","volume":"3","author":"FC Origgi","year":"2000","unstructured":"Origgi FC, Jacobson ER. Diseases of the respiratory tract of chelonians. Vet Clin North America. 2000;3(2):537\u201349.","journal-title":"Vet Clin North America"},{"issue":"3","key":"2324_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1638\/1042-7260(2000)031[0303:MAMAWA]2.0.CO;2","volume":"31","author":"TL Clippinger","year":"2000","unstructured":"Clippinger TL, Bennett RA, Johnson CM, Vliet KA, Deem SL, Oros J, et al. Morbidity and mortality associated with a new mycoplasma species from captive American alligators (Alligator mississippiensis). J Zoo Wildl Med. 2000;31(3):303\u201314.","journal-title":"J Zoo Wildl Med"},{"key":"2324_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/B978-0-12-409527-4.00004-3","volume-title":"Laboratory animal medicine","author":"GM Otto","year":"2015","unstructured":"Otto GM, Franklin CL, Clifford CB, Fox JG, Anderson LC, Pritchett-Corning KR, et al. Chapter 4 - biology and diseases of rats. In: Laboratory animal medicine. 3rd ed. Boston: Academic Press; 2015. p. 151\u2013207.","edition":"3"},{"issue":"3\u20134","key":"2324_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.vetmic.2011.02.005","volume":"150","author":"S Gharaibeh","year":"2011","unstructured":"Gharaibeh S, Al-Rashdan M. Change in antimicrobial susceptibility of Mycoplasma gallisepticum field isolates. Vet Microbiol. 2011;150(3\u20134):379\u201383.","journal-title":"Vet Microbiol"},{"issue":"3","key":"2324_CR7","doi-asserted-by":"publisher","first-page":"e0174700","DOI":"10.1371\/journal.pone.0174700","volume":"12","author":"J Tatay-Dualde","year":"2017","unstructured":"Tatay-Dualde J, Prats-van der Ham M, de la Fe C, Paterna A, Sanchez A, Corrales JC, et al. Antimicrobial susceptibility and multilocus sequence typing of Mycoplasma capricolum subsp. capricolum. PLoS One. 2017;12(3):e0174700.","journal-title":"PLoS One"},{"key":"2324_CR8","doi-asserted-by":"publisher","unstructured":"Gautier-Bouchardon AV. Antimicrobial resistance in Mycoplasma spp. Microbiol Spectr. 2018;6(4). https:\/\/doi.org\/10.1128\/microbiolspec.ARBA-0030-2018.","DOI":"10.1128\/microbiolspec.ARBA-0030-2018"},{"key":"2324_CR9","doi-asserted-by":"crossref","unstructured":"Brown DR. Phylum XVI. Tenericutes Murray 1984a, 356VP (effective publication: Murray 1984b, 33.). In: Krieg NR, Staley JT, Brown DR, Hedlund BP, Paster BJ, Ward NL, et al., editors. Bergey\u2019s manual\u00ae of systematic bacteriology: volume four the Bacteroidetes, Spirochaetes, Tenericutes (Mollicutes), Acidobacteria, Fibrobacteres, Fusobacteria, Dictyoglomi, Gemmatimonadetes, Lentisphaerae, Verrucomicrobia, Chlamydiae, and Planctomycetes. New York, NY: Springer New York; 2010. p. 567\u2013723.","DOI":"10.1007\/978-0-387-68572-4_5"},{"key":"2324_CR10","first-page":"25","volume":"6","author":"RJ Fair","year":"2014","unstructured":"Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Med Chem. 2014;6:25\u201364.","journal-title":"Perspect Med Chem"},{"issue":"1\u20132","key":"2324_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.vetmic.2012.05.002","volume":"160","author":"I Lysnyansky","year":"2012","unstructured":"Lysnyansky I, Gerchman I, Levisohn S, Mikula I, Feberwee A, Ferguson NM, et al. Discrepancy between minimal inhibitory concentration to enrofloxacin and mutations present in the quinolone-resistance determining regions of Mycoplasma gallisepticum field strains. Vet Microbiol. 2012;160(1\u20132):222\u20136.","journal-title":"Vet Microbiol"},{"key":"2324_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1297-9716-42-90","volume":"42","author":"I Gerchman","year":"2011","unstructured":"Gerchman I, Levisohn S, Mikula I, Manso-Silv\u00e1n L, Lysnyansky I. Characterization of in vivo-acquired resistance to macrolides of Mycoplasma gallisepticum strains isolated from poultry. Vet Res. 2011;42:90.","journal-title":"Vet Res"},{"issue":"8","key":"2324_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3855\/jidc.7850","volume":"10","author":"AM Ammar","year":"2016","unstructured":"Ammar AM, Abd El-Aziz NK, Gharib AA, Ahmed HK, Lameay AE. Mutations of domain V in 23S ribosomal RNA of macrolide-resistant Mycoplasma gallisepticum isolates in Egypt. J Infect Dev Ctries. 2016;10(8):807\u201313.","journal-title":"J Infect Dev Ctries"},{"key":"2324_CR14","doi-asserted-by":"crossref","unstructured":"Beylefeld A, Wambulawaye P, Bwala DG, Gouws JJ, Lukhele OM, Wandrag DBR, et al. Evidence for multidrug resistance in nonpathogenic Mycoplasma species isolated from South African poultry. Appl Environ Microbiol. 2018;84(21).","DOI":"10.1128\/AEM.01660-18"},{"issue":"4","key":"2324_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1051\/vetres:2000100","volume":"31","author":"PC Hannan","year":"2000","unstructured":"Hannan PC. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. International research Programme on comparative Mycoplasmology. Vet Res. 2000;31(4):373\u201395.","journal-title":"Vet Res"},{"issue":"3","key":"2324_CR16","doi-asserted-by":"publisher","first-page":"848","DOI":"10.20506\/rst.16.3.1062","volume":"16","author":"D Bergonier","year":"1997","unstructured":"Bergonier D, Berthelot X, Poumarat F. Contagious agalactia of small ruminants: current knowledge concerning epidemiology, diagnosis and control. Rev Sci Tech. 1997;16(3):848\u201373.","journal-title":"Rev Sci Tech"},{"key":"2324_CR17","doi-asserted-by":"publisher","DOI":"10.1079\/9780851990125.0000","volume-title":"Mycoplasma diseases of ruminants : disease, diagnosis and control","author":"R Nicholas","year":"2008","unstructured":"Nicholas R, Ayling R, McAuliffe L. Mycoplasma diseases of ruminants : disease, diagnosis and control. Wallingford, United Kingdom: CABI; 2008."},{"issue":"1","key":"2324_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11250-006-4334-3","volume":"38","author":"W Al-Momani","year":"2006","unstructured":"Al-Momani W, Nicholas RA, Janakat S, Abu-Basha E, Ayling RD. The in vitro effect of six antimicrobials against Mycoplasma putrefaciens, Mycoplasma mycoides subsp. mycoides LC and Mycoplasma capricolum subsp. capricolum isolated from sheep and goats in Jordan. Trop Anim Health Prod. 2006;38(1):1\u20137.","journal-title":"Trop Anim Health Prod"},{"issue":"1","key":"2324_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rvsc.2004.10.002","volume":"79","author":"VJ Chalker","year":"2005","unstructured":"Chalker VJ. Canine mycoplasmas. Res Vet Sci. 2005;79(1):1\u20138.","journal-title":"Res Vet Sci"},{"issue":"4","key":"2324_CR20","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1939-1676.2012.00954.x","volume":"26","author":"RM Barber","year":"2012","unstructured":"Barber RM, Porter BF, Li Q, May M, Claiborne MK, Allison AB, et al. Broadly reactive polymerase chain reaction for pathogen detection in canine granulomatous meningoencephalomyelitis and necrotizing meningoencephalitis. J Vet Intern Med. 2012;26(4):962\u20138.","journal-title":"J Vet Intern Med"},{"key":"2324_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1746-6148-6-32","volume":"6","author":"M Chazel","year":"2010","unstructured":"Chazel M, Tardy F, Le Grand D, Calavas D, Poumarat F. Mycoplasmoses of ruminants in France: recent data from the national surveillance network. BMC Vet Res. 2010;6:32.","journal-title":"BMC Vet Res"},{"key":"2324_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nmni.2018.05.003","volume":"25","author":"S Klein","year":"2018","unstructured":"Klein S, Klotz M, Eigenbrod T. First isolation of Mycoplasma canis from human tissue samples after a dog bite. New Microbes New Infect. 2018;25:14\u20135.","journal-title":"New Microbes New Infect"},{"issue":"2","key":"2324_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1638\/04-029.1","volume":"36","author":"DR Brown","year":"2005","unstructured":"Brown DR, Zacher LA, Carbonneau DA. Seroprevalence of Mycoplasma alligatoris among free-ranging alligators (Alligator mississippiensis) in Florida\u20142003. J Zoo Wildl Med. 2005;36(2):340\u20131.","journal-title":"J Zoo Wildl Med"},{"issue":"2","key":"2324_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1638\/1042-7260(2002)033[0108:IVDSPO]2.0.CO;2","volume":"33","author":"KE Helmick","year":"2002","unstructured":"Helmick KE, Brown DR, Jacobson ER, Brown MB. In vitro drug susceptibility pattern of Mycoplasma alligatoris isolated from symptomatic American alligators (Alligator mississippiensis). J Zoo Wildl Med. 2002;33(2):108\u201311.","journal-title":"J Zoo Wildl Med"},{"issue":"3","key":"2324_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tvjl.2014.05.039","volume":"201","author":"ER Jacobson","year":"2014","unstructured":"Jacobson ER, Brown MB, Wendland LD, Brown DR, Klein PA, Christopher MM, et al. Mycoplasmosis and upper respiratory tract disease of tortoises: a review and update. Vet J. 2014;201(3):257\u201364.","journal-title":"Vet J"},{"issue":"Pt 2","key":"2324_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1099\/00207713-51-2-413","volume":"51","author":"MB Brown","year":"2001","unstructured":"Brown MB, Brown DR, Klein PA, McLaughlin GS, Schumacher IM, Jacobson ER, et al. Mycoplasma agassizii sp. nov., isolated from the upper respiratory tract of the desert tortoise (Gopherus agassizii) and the gopher tortoise (Gopherus polyphemus). Int J Syst Evol Microbiol. 2001;51(Pt 2):413\u20138.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"3","key":"2324_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1034\/j.1600-0897.2001.d01-7.x","volume":"46","author":"MB Brown","year":"2001","unstructured":"Brown MB, Peltier M, Hillier M, Crenshaw B, Reyes L. Genital mycoplasmosis in rats: a model for intrauterine infection. Am J Reprod Immunol. 2001;46(3):232\u201341.","journal-title":"Am J Reprod Immunol"},{"key":"2324_CR28","unstructured":"Charles River Research Models and Services: Mycoplasma pulmonis: Technical Sheet. 2009. https:\/\/www.criver.com\/sites\/default\/files\/resources\/MycoplasmapulmonisTechnicalSheet.pdf. Accessed 08 March 2020."},{"issue":"2","key":"2324_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1128\/CMR.11.2.231","volume":"11","author":"DG Baker","year":"1998","unstructured":"Baker DG. Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin Microbiol Rev. 1998;11(2):231\u201366.","journal-title":"Clin Microbiol Rev"},{"key":"2324_CR30","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1039\/C6MD00381H","volume":"8","author":"AT Garrison","year":"2017","unstructured":"Garrison AT, Abouelhassan Y, Yang H, Yousaf HH, Nguyen TJ, Huigens RW III. Microwave-enhanced Friedl\u00e4nder synthesis for the rapid assembly of halogenated quinolines with antibacterial and biofilm eradication activities against drug resistant and tolerant bacteria. Med Chem Commun. 2017;8:720\u20134.","journal-title":"Med Chem Commun"},{"issue":"41","key":"2324_CR31","doi-asserted-by":"publisher","first-page":"10290","DOI":"10.1039\/C5OB01883H","volume":"13","author":"A Basak","year":"2015","unstructured":"Basak A, Abouelhassan Y, Huigens RW. Halogenated quinolines discovered through reductive amination with potent eradication activities against MRSA, MRSE and VRE biofilms. Org Biomol Chem. 2015;13(41):10290\u20134.","journal-title":"Org Biomol Chem"},{"issue":"4","key":"2324_CR32","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/cbic.201600622","volume":"18","author":"Y Abouelhassan","year":"2017","unstructured":"Abouelhassan Y, Basak A, Yousaf H, Huigens RW 3rd. Identification of N-arylated NH125 analogues as rapid eradicating agents against MRSA persister cells and potent biofilm killers of gram-positive pathogens. Chembiochem. 2017;18(4):352\u20137.","journal-title":"Chembiochem"},{"issue":"2","key":"2324_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1067\/mic.2000.102378","volume":"28","author":"RD Jones","year":"2000","unstructured":"Jones RD, Jampani HB, Newman JL, Lee AS. Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control. 2000;28(2):184\u201396.","journal-title":"Am J Infect Control"},{"issue":"5","key":"2324_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/10408441003667514","volume":"40","author":"JV Rodricks","year":"2010","unstructured":"Rodricks JV, Swenberg JA, Borzelleca JF, Maronpot RR, Shipp AM. Triclosan: a critical review of the experimental data and development of margins of safety for consumer products. Crit Rev Toxicol. 2010;40(5):422\u201384.","journal-title":"Crit Rev Toxicol"},{"key":"2324_CR35","doi-asserted-by":"publisher","unstructured":"Valentine-King MA, Cisneros K, James MO, Huigens RW 3rd, Brown MB. Turning the tide against antibiotic resistance by evaluating novel, halogenated phenazine, quinoline, and NH125 compounds against Ureaplasma spp. clinical isolates and Mycoplasma type strains. Antimicrob Agents Chemother. 2019;63(3). https:\/\/doi.org\/10.1128\/AAC.02265-18.","DOI":"10.1128\/AAC.02265-18"},{"key":"2324_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fmicb.2016.00595","volume":"7","author":"I Lysnyansky","year":"2016","unstructured":"Lysnyansky I, Ayling RD. Mycoplasma bovis: mechanisms of resistance and trends in antimicrobial susceptibility. Front Microbiol. 2016;7:595.","journal-title":"Front Microbiol"},{"key":"2324_CR37","unstructured":"Ley DH. Mycoplasma gallisepticum infection in poultry. In: Merck Veterinary Manual. Merck Sharp & Dohme Corp. 2016. https:\/\/www.merckvetmanual.com\/poultry\/mycoplasmosis\/mycoplasma-gallisepticum-infection-in-poultry#v3342225. Accessed 02 Jan 2019."},{"issue":"11","key":"2324_CR38","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1128\/JCM.01439-12","volume":"50","author":"KB Waites","year":"2012","unstructured":"Waites KB, Duffy LB, Bebear CM, Matlow A, Talkington DF, Kenny GE, et al. Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum. J Clin Microbiol. 2012;50(11):3542\u20137.","journal-title":"J Clin Microbiol"},{"issue":"26","key":"2324_CR39","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1039\/C7OB01028A","volume":"15","author":"A Basak","year":"2017","unstructured":"Basak A, Abouelhassan Y, Zuo R, Yousaf H, Ding Y, Huigens RW. Antimicrobial peptide-inspired NH125 analogues: bacterial and fungal biofilm-eradicating agents and rapid killers of MRSA persisters. Org Biomol Chem. 2017;15(26):5503\u201312.","journal-title":"Org Biomol Chem"},{"issue":"23","key":"2324_CR40","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1002\/cbic.201900116","volume":"20","author":"RW Huigens","year":"2019","unstructured":"Huigens RW, Abouelhassan Y, Yang H. Phenazine antibiotic-inspired discovery of bacterial biofilm-eradicating agents. Chembiochem. 2019;20(23):2885\u2013902.","journal-title":"Chembiochem"},{"issue":"8","key":"2324_CR41","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1021\/acs.jmedchem.5b02004","volume":"59","author":"AT Garrison","year":"2016","unstructured":"Garrison AT, Abouelhassan Y, Norwood VM, Kallifidas D, Bai F, Nguyen MT, et al. Structure-activity relationships of a diverse class of halogenated phenazines that targets persistent, antibiotic-tolerant bacterial biofilms and Mycobacterium tuberculosis. J Med Chem. 2016;59(8):3808\u201325.","journal-title":"J Med Chem"},{"issue":"3","key":"2324_CR42","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1128\/AAC.39.3.707","volume":"39","author":"C Pelletier","year":"1995","unstructured":"Pelletier C, Prognon P, Bourlioux P. Roles of divalent cations and pH in mechanism of action of nitroxoline against Escherichia coli strains. Antimicrob Agents Chemother. 1995;39(3):707\u201313.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 4","key":"2324_CR43","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1099\/mic.0.28674-0","volume":"152","author":"ML Madsen","year":"2006","unstructured":"Madsen ML, Nettleton D, Thacker EL, Minion FC. Transcriptional profiling of Mycoplasma hyopneumoniae during iron depletion using microarrays. Microbiology. 2006;152(Pt 4):937\u201344.","journal-title":"Microbiology"},{"key":"2324_CR44","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ejmech.2018.06.045","volume":"155","author":"A Basak","year":"2018","unstructured":"Basak A, Abouelhassan Y, Kim YS, Norwood VM, Jin S, Huigens RW. Halogenated quinolines bearing polar functionality at the 2-position: identification of new antibacterial agents with enhanced activity against Staphylococcus epidermidis. Eur J Med Chem. 2018;155:705\u201313.","journal-title":"Eur J Med Chem"},{"key":"2324_CR45","unstructured":"Valentine-King M, Cisneros K, James M, Huigens R, Brown M: A TL1 team approach to evaluating novel antimicrobial compounds against mycoplasmas and their interaction with drug metabolizing enzymes. In: Translational Science 2018. Washington, D. C.; 2018."},{"issue":"4","key":"2324_CR46","first-page":"1111","volume":"11","author":"L Li","year":"2012","unstructured":"Li L, Shen W, Zhang K, Tang X, Guo N, Shen F, et al. In-vitro antimycoplasmal activity of triclosan in combination with fluoroquinolones against five Mycoplasma species. Iran J Pharm Res. 2012;11(4):1111\u20139.","journal-title":"Iran J Pharm Res"},{"issue":"6","key":"2324_CR47","doi-asserted-by":"publisher","first-page":"064501","DOI":"10.1289\/EHP1788","volume":"125","author":"RU Halden","year":"2017","unstructured":"Halden RU, Lindeman AE, Aiello AE, Andrews D, Arnold WA, Fair P, et al. The Florence statement on triclosan and triclocarban. Environ Health Perspect. 2017;125(6):064501.","journal-title":"Environ Health Perspect"},{"key":"2324_CR48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.toxlet.2018.05.014","volume":"294","author":"EN Jackson","year":"2018","unstructured":"Jackson EN, Rowland-Faux L, James MO, Wood CE. Administration of low dose triclosan to pregnant ewes results in placental uptake and reduced estradiol sulfotransferase activity in fetal liver and placenta. Toxicol Lett. 2018;294:116\u201321.","journal-title":"Toxicol Lett"},{"issue":"1\u20132","key":"2324_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.vetmic.2012.07.013","volume":"161","author":"H Chen","year":"2012","unstructured":"Chen H, Yu S, Hu M, Han X, Chen D, Qiu X, et al. Identification of biofilm formation by Mycoplasma gallisepticum. Vet Microbiol. 2012;161(1\u20132):96\u2013103.","journal-title":"Vet Microbiol"},{"issue":"2","key":"2324_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijantimicag.2016.10.017","volume":"49","author":"Y Abouelhassan","year":"2017","unstructured":"Abouelhassan Y, Yang Q, Yousaf H, Nguyen MT, Rolfe M, Schultz GS, et al. Nitroxoline: a broad-spectrum biofilm-eradicating agent against pathogenic bacteria. Int J Antimicrob Agents. 2017;49(2):247\u201351.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"2324_CR51","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1128\/JB.01512-06","volume":"189","author":"WL Simmons","year":"2007","unstructured":"Simmons WL, Bolland JR, Daubenspeck JM, Dybvig K. A stochastic mechanism for biofilm formation by Mycoplasma pulmonis. J Bacteriol. 2007;189(5):1905\u201313.","journal-title":"J Bacteriol"},{"issue":"Pt 4","key":"2324_CR52","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1099\/mic.0.28604-0","volume":"152","author":"L McAuliffe","year":"2006","unstructured":"McAuliffe L, Ellis RJ, Miles K, Ayling RD, Nicholas RA. Biofilm formation by mycoplasma species and its role in environmental persistence and survival. Microbiology. 2006;152(Pt 4):913\u201322.","journal-title":"Microbiology"},{"key":"2324_CR53","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. CLSI document M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute; 2012."},{"issue":"1","key":"2324_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/AAC.47.1.161-165.2003","volume":"47","author":"KB Waites","year":"2003","unstructured":"Waites KB, Crabb DM, Bing X, Duffy LB. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother. 2003;47(1):161\u20135.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02324-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-020-02324-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02324-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T19:13:03Z","timestamp":1666293183000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-020-02324-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2324"],"URL":"https:\/\/doi.org\/10.1186\/s12917-020-02324-4","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]},"assertion":[{"value":"19 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}